Organisation paid for research Program year 2025 Source: CMS Open Payments

Infusion Associates

Neither a doctor nor a teaching hospital

Research payments

$884,445

91 payments

Through program year 2025, Infusion Associates is reported as receiving $884,445 in research payments, across 91 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$121,923	1
2024	Research	$431,120	23
2023	Research	$331,144	65
2021	Research	$192	1
2020	Research	$65	1

Breakdown

Who paid Research payments · program years 2020–2025

AstraZeneca UK Limited $762,240 3 payments
ViiV Healthcare Company $100,248 81 payments
Sanofi US Services Inc. $21,700 5 payments
E.R. Squibb & Sons, L.L.C. $257 2 payments

Studies the money was for Research payments · program years 2020–2025

A Phase I-III Randomized Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156-AZD3152 for Pre exposure Prophylaxis of COVID 19 in Participants with Conditions Causing Immune Impairment $762,240 3 payments
A Phase 4, Open-Label, Single Arm Study to Optimize Implementation of $100,248 81 payments
Fabry Disease Registry Protocol $20,550 3 payments
Pompe Disease Registry $1,150 2 payments
Phase 2 UC Primary represents Induction $192 1 payment
Phase 2 UC $65 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.